Background: Cytokine induction of the enzyme indoleamine 2,3-dioxygenase (IDO) has been implicated in the development of major depressive disorder (MDD). IDO metabolizes tryptophan (TRP) into kynurenine (KYN), thereby decreasing TRP availability to the brain. KYN is further metabolized into several neurotoxins. The aims of this pilot were to examine possible relationships between plasma TRP, KYN, and 3-hydroxyanthranilic acid (3-HAA, neurotoxic metabolite) and striatal total choline (tCho, cell membrane turnover biomarker) in adolescents with MDD. We hypothesized that MDD adolescents would exhibit: i) positive correlations between KYN and 3-HAA and striatal tCho and a negative correlation between TRP and striatal tCho; and, ii) the anticipated correlations would be more pronounced in the melancholic subtype group. Methods: Fourteen adolescents with MDD (seven with melancholic features) and six healthy controls were enrolled. Minimums of 6 weeks MDD duration and a severity score of 40 on the Children's Depression Rating Scale-Revised were required. All were scanned at 3 T with MRI, multi-voxel 3-dimensional, high, 0.75 cm 3 , spatial resolution proton magnetic resonance spectroscopic imaging. Striatal tCho concentrations were assessed using phantom replacement. Spearman correlation coefficients were Bonferroni-corrected. Results: Positive correlations were found only in the melancholic group, between KYN and 3-HAA and tCho in the right caudate (r = 0.93, p = 0.03) and the left putamen (r = 0.96, p = .006), respectively. Conclusions: These preliminary findings suggest a possible role of the KYN pathway in adolescent melancholic MDD. Larger studies should follow.
Introduction
Research of adolescent major depressive disorder (MDD) is highly important in light of the disorder's significant morbidity, and most critically, risk of suicide. Moreover, focusing on early-onset MDD may minimize the confounding effects of chronicity, treatment, and aging. At the same time, there is consensus that adolescent MDD is a heterogeneous clinical syndrome that reflects multiple etiologies. Yet, research identifying biological correlates of clinical subtypes of adolescent MDD has been scarce.
Mounting evidence has linked immune system activation with MDD. Clinical studies have documented increased pro-inflammatory cytokine plasma levels in adult and pediatric MDD (Gabbay et al., 2009; Irwin and Miller, 2007) . One possible pathway linking cytokines with MDD involves the induction of the enzyme indoleamine 2,3-dioxygenase (IDO) by pro-inflammatory cytokines, particularly interferon-γ. IDO is the rate-limiting enzyme of the kynurenine pathway (KP) which metabolizes tryptophan (TRP) into kynurenine (KYN), thereby shunting TRP from the synthesis of serotonin. KYN is further metabolized into several neurotoxins, including 3-hydroxykynurenine (3-HK), 3-hydroxyanthranilic acid (3-HAA), and quinolinic acid (QUIN) (Goldstein et al., 2000; Schwarcz et al., 1983) . In a competing branch of the KP, KYN is metabolized into kynurenic acid (KA), which blocks the neurotoxic effects of QUIN (Sapko et al., 2006) .
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